Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002060873-25-000001
Filing Date
2025-03-18
Accepted
2025-03-18 12:17:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5786
  Complete submission text file 0002060873-25-000001.txt   7411
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Subject) CIK: 0001826892 (see all company filings)

EIN.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91930 | Film No.: 25747096
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address KROLEWSKA 18 WARSAW R9 00-103
Business Address KROLEWSKA 18 WARSAW R9 00-103 48667700773
OPOKA INVESTMENT FUND Co (Filed by) CIK: 0002060873 (see all company filings)

EIN.: 000000000 | State of Incorp.: R9 | Fiscal Year End: 1231
Type: SCHEDULE 13G